Can the antibiogram be used to assess microbiologic outcomes after antimicrobial stewardship interventions? A critical review of the literature

Pharmacotherapy

Volumn 32, Issue 8, 2012, Pages 668-676

  Schulz, Lucas T ^a   Fox, Barry C ^a,b   Polk, Ron E ^a,c  

^a University of Pharmacy   (United States)

^b University of Wisconsin Health   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antibiogram; Antimicrobial management; Antimicrobial resistance; Antimicrobial stewardship; Interrupted time series analysis

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEFAZOLIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL EFFECTIVENESS; COMPUTER PROGRAM; DECISION SUPPORT SYSTEM; DRUG CONTROL; DRUG MONITORING; DRUG USE; HEALTH PROGRAM; HOSPITAL SERVICE; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES AS TOPIC;

EID: 84864597256     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01163.x     Document Type: Review

References (35)

1. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-77.
2. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:322-7.
3. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: A review of general principles and contemporary practices. Clin Infect Dis 2009;49:1749-55.
4. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: A new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867-73.
5. Xu R, Polk RE, Stencel L, et al. Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines. Am J Health Syst Pharm 2012;69:598-606.
6. Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline, 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2005:CLSI document M39-A2 (ISBN 1-56238-585-2).
7. Xie C, Taylor DM, Howden BP, Charles PG. Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J 2011; Jan 17. doi: 10.1111/j.1445-5994.2011. 02436.x. [Epub ahead of print].
8. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in long-term acute care hospitals: The perfect storm. Infect Control Hosp Epidemiol 2006;27:920-5.
9. Fox BC, Shenk G, Peterson D, Maki DG. Differences in institutional antibiograms for gram-negative bacilli based on use of the latest patient isolate and unit-specific data. In. 44th Annual Meeting of the IDSA, Toronto, ON, Canada; October 12-15th, 2006.
10. Hebert C, Ridgway J, Vekhter B, Brown EC, Weber SG, Robicsek A. Demonstration of the weighted-incidence syndromic combination antibiogram: An empiric prescribing decision aid. Infect Control Hosp Epidemiol 2012;33:381-8.
11. Fox BC, Shenk G, Peterson D, Spiegel CA, Maki DG. Choosing more effective antimicrobial combinations for empiric anti-microbial therapy of serious gram-negative rod infections using a dual cross-table antibiogram. Am J Infect Control 2008;36:S57-61.
12. Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies-what are we missing? Nat Rev Microbiol 2004;2:979-83.
13. McGowan JE. Antimicrobial stewardship-the state of the art in 2011: Focus on outcome and methods. Infect Control Hosp Epidemiol 2012;33:331-7.
14. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae-EUCAST and CLSI breakpoints. Clin Microbiol Infect 2008;14(Suppl 1):169-74.
15. Ababneh M, Harpe S, Oinonen M, Polk R. Aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in U.S. academic medical centers: Implications for antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:594-601.
16. Davey P, Brown E, Fenelon L, et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 2006;12:211-6.
17. McGowan JE, Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-83.
18. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
19. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 2004;53:853-9.
20. Cook PP, Das TD, Gooch M, Catrou PG. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents. Infect Control Hosp Epidemiol 2008;29:716-22.
21. Burke JP. Antibiotic resistance-squeezing the balloon? JAMA 1998;280:1270-1.
22. Buising KL, Thursky KA, Robertson MB, et al. Electronic antibiotic stewardship-reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother 2008;62:608-16.
23. Chan YY, Lin TY, Huang CT, et al. Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan. Int J Antimicrob Agents 2011;38:486-92.
24. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001;33:1462-8.
25. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175-83.
26. Burke JP, Pestotnik SL. Antibiotic use and microbial resistance in intensive care units: Impact of computer-assisted decision support. J Chemother 1999;11:530-5.
27. Yong MK, Buising KL, Cheng AC, Thursky KA. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 2010; 65:1062-9.
28. Slain D, Sarwari AR, Petros KO, et al. Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract 2011;2011:416426.
29. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: Guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007;7:282-8.
30. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45:901-7.
31. Lopez-Lozano JM, Monnet DL, Yague A, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis. Int J Antimicrob Agents 2000;14:21-31.
32. Bosso JA, Mauldin PD. Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:2106-12.
33. Elligsen M, Walker SA, Pinto R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: A controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2012;33:354-61.
34. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the rate of nosocomial Methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006;27:155-169.
35. Ramsay C, Brown E, Hartman G, Davey P. On behalf of the joint BSAC/HIS Working Party on Optimization of Antibiotic Prescribing in Hospitals. Room for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. Journal of Antimicrobial Chemotherapy 2003;52:764-771.